682 related articles for article (PubMed ID: 22437818)
1. ECVAM and new technologies for toxicity testing.
Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
[TBL] [Abstract][Full Text] [Related]
4. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
[TBL] [Abstract][Full Text] [Related]
5. Consensus report on the future of animal-free systemic toxicity testing.
Leist M; Hasiwa N; Rovida C; Daneshian M; Basketter D; Kimber I; Clewell H; Gocht T; Goldberg A; Busquet F; Rossi AM; Schwarz M; Stephens M; Taalman R; Knudsen TB; McKim J; Harris G; Pamies D; Hartung T
ALTEX; 2014; 31(3):341-56. PubMed ID: 25061899
[TBL] [Abstract][Full Text] [Related]
6. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
7. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
Llorens J; Li AA; Ceccatelli S; Suñol C
Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
[TBL] [Abstract][Full Text] [Related]
8. The way forward in reproductive/developmental toxicity testing.
Spielmann H
Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
[TBL] [Abstract][Full Text] [Related]
9. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
10. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
11. New animal-free concepts and test methods for developmental toxicity and peripheral neurotoxicity.
Leist M
Altern Lab Anim; 2017 Nov; 45(5):253-260. PubMed ID: 29112453
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
Beken S; Kasper P; van der Laan JW
Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
[TBL] [Abstract][Full Text] [Related]
13. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
14. Alternative test methods in inhalation toxicology: challenges and opportunities.
Costa DL
Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
[TBL] [Abstract][Full Text] [Related]
15. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy'': stem cells and cell-cell communication as fundamental targets in assessing the potential toxicity of chemicals.
Trosko JE
Hum Exp Toxicol; 2010 Jan; 29(1):21-9. PubMed ID: 20061464
[TBL] [Abstract][Full Text] [Related]
16. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
Zuang V
Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
[TBL] [Abstract][Full Text] [Related]
17. Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.
Shinde V; Klima S; Sureshkumar PS; Meganathan K; Jagtap S; Rempel E; Rahnenführer J; Hengstler JG; Waldmann T; Hescheler J; Leist M; Sachinidis A
J Vis Exp; 2015 Jun; (100):e52333. PubMed ID: 26132533
[TBL] [Abstract][Full Text] [Related]
18. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
[TBL] [Abstract][Full Text] [Related]
19. Do we need a "Chair of alternative methods", and where?
Wendel A
ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
[TBL] [Abstract][Full Text] [Related]
20. Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration.
Pallocca G; Grinberg M; Henry M; Frickey T; Hengstler JG; Waldmann T; Sachinidis A; Rahnenführer J; Leist M
Arch Toxicol; 2016 Jan; 90(1):159-80. PubMed ID: 26705709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
